GF Fund Management
RIGL icon

GF Fund Management’s Rigel Pharmaceuticals RIGL Stock Holding History

GF Fund Management’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$19.9K Buy
413
+32
+8% +$1.39K ﹤0.01% 497
2026
Q2 		$14.9K Sell
381
-26
-6% -$802 ﹤0.01% 506
2026
Q1 		$11K Buy
407
+51
+14% +$1.71K ﹤0.01% 552
2025
Q4 		$15.2K Sell
356
-28
-7% -$1.06K ﹤0.01% 537
2025
Q3 		$10.9K Sell
384
-67
-15% -$2K ﹤0.01% 548
2025
Q2 		$8.45K Hold
451
– – ﹤0.01% 584
2025
Q1 		$8.11K Buy
451
+81
+22% +$1.64K ﹤0.01% 585
2024
Q4 		$6.22K Buy
+370
New +$7.1K ﹤0.01% 600

Other funds holding RIGL

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Burney Company
Burney Company Reston, Virginia $3.66B AUM 27.59% 1-Year Est. Return
Sterling Capital Management
Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return
ALPS Advisors
ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
STRS Ohio
STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return
SummerHaven Investment Management
SummerHaven Investment Management Stamford, Connecticut $179M AUM 57.61% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return

GF Fund Management's RIGL Position: Q3 2026 in Review

GF Fund Management increased its Rigel Pharmaceuticals (RIGL) stake by 8.4% in Q3 2026, buying an estimated $1.39K and bringing the position to 413 shares worth $19.9K. The position accounts for ﹤0.01% of the portfolio, ranked #497.

GF Fund Management first reported a position in RIGL in Q4 2024 and has held it in 8 quarters since. 44 funds tracked by Wall St. Rank hold RIGL as of Q3 2026.

  • GF Fund Management held 413 shares of Rigel Pharmaceuticals worth $19.9K as of Q3 2026.
  • GF Fund Management bought 32 Rigel Pharmaceuticals shares in Q3 2026, an estimated $1.39K.
  • Rigel Pharmaceuticals made up ﹤0.01% of GF Fund Management's portfolio in Q3 2026, its #497 holding.
  • GF Fund Management first reported a position in Rigel Pharmaceuticals in Q4 2024 and has held it in 8 quarters since.
  • 44 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q3 2026.

Based on GF Fund Management's 13F filing for Q3 2026, filed 26 Oct 2026.